top of page

KiraGen moves into Harvard Pagliuca Life Lab!



We're excited to share a pivotal update from KiraGen Bio: our move to the Harvard Pagliuca Harvard Life Lab. This transition is a significant stride in our quest to revolutionize CAR-T cell therapies for solid tumors, positioning us within a hub of biotech innovation. The Life Lab's state-of-the-art facilities and vibrant community enhance our capability to tackle the tumor microenvironment and refine gene editing for more effective cancer treatments.

This move amplifies our efforts, connecting us with fellow innovators and expanding our reach in the biotech landscape. It's a leap forward in our mission, promising to accelerate our impact on cancer therapy. Join us on this exhilarating journey as we continue to push the boundaries of medical science.

Comments


bottom of page